3164 — Genmont Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMicro CapFalling Star

Annual balance sheet for Genmont Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	465	422	401	328	426
Net Total Accounts Receivable
Net Total Receivables	46.4	55.1	51.8	40	33.3
Total Inventory
Prepaid Expenses
Total Current Assets	596	581	522	466	542
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	954	1,059	1,113	1,060	1,037
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,613	1,698	1,696	1,653	1,709
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	95	139	161	146	140
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	284	322	344	337	357
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,329	1,376	1,351	1,316	1,352
Total Liabilities & Shareholders' Equity	1,613	1,698	1,696	1,653	1,709
Total Common Shares Outstanding